Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2022

Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods

Résumé

Meeting Abstract PS-035
Fichier non déposé

Dates et versions

hal-03789389 , version 1 (27-09-2022)

Identifiants

  • HAL Id : hal-03789389 , version 1

Citer

C. Tron, F. Lemaitre, P. Bros, C. Goulvestre, B. Franck, et al.. Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods. Fundamental & Clinical Pharmacology, 2022, 36, pp.110-110. ⟨hal-03789389⟩
10 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More